Menu +

Information for Investors

Corcept Therapeutics is a pharmaceutical company engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders, with a focus on disorders associated with the steroid hormone cortisol.

Corcept Therapeutics Incorporated

Symbol: CORT
Exchange: NASDAQ

Stock Quote at 9/25/2016 4:26 ET
Last Trade: 6.49 Days Range: 6.36 - 6.56
Trade Time: 4:00pm ET 52wk Range: 3.22 - 6.60
Change: +0.00 (0.00%) Volume: 301,279
Prev Close: 6.49 Open: 6.48
Bid: 6.49 P/E: 721.11
Ask: 8.00 EPS: 0.01


Quotes delayed up to 30 minutes

Investor Relations Contact Information

Phone: 650-327-3270
Email: ir@corcept.com

Sign up to receive Corcept press releases via email

* Field is required

Quotes are provided by EDGAR Online and are delayed at least 20 minutes. Corcept Therapeutics is not responsible for the accuracy of this information or any actions that may be taken based on this information. Current and historical stock price data is not necessarily indicative of future performance.

built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
Cancel Continue